BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26903428)

  • 41. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
    Croxatto HB
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
    Moeti DMP; Govender I; Bongongo T
    S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tamoxifen for the Treatment of Etonogestrel Implant-Associated Bleeding in an Adolescent Gynecology Practice.
    Friedman JC; Buyers E; Laurin J; Hampanda K; Alaniz VI
    J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):341-345. PubMed ID: 34780932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
    Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
    Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?
    Tocce KM; Sheeder JL; Teal SB
    Am J Obstet Gynecol; 2012 Jun; 206(6):481.e1-7. PubMed ID: 22631865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Etonogestrel contraceptive implant-associated secondary anorgasmia.
    Chapa HO; Ramirez A; Dawson D
    Contraception; 2017 Oct; 96(4):254-256. PubMed ID: 28666796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "I think it depends on the body, with mine it didn't work": explaining young women's contraceptive implant removal.
    Hoggart L; Newton VL; Dickson J
    Contraception; 2013 Nov; 88(5):636-40. PubMed ID: 23829976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Australian women's experience with Implanon.
    Weisberg E; Fraser I
    Aust Fam Physician; 2005 Aug; 34(8):694-6. PubMed ID: 16113711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population.
    Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C
    Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
    Pakarinen P; Luukkainen T
    Contraception; 2005 Nov; 72(5):342-5. PubMed ID: 16246659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Insertion problems, removal problems, and contraception failures with Implanon].
    Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F; Llabres S; Autret-Leca E;
    Gynecol Obstet Fertil; 2005 Dec; 33(12):986-90. PubMed ID: 16321557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting.
    Lakha F; Glasier AF
    Contraception; 2006 Oct; 74(4):287-9. PubMed ID: 16982226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.
    Romano ME; Braun-Courville DK
    J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):409-414. PubMed ID: 30928532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.